Welcome to eviQ
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
The COVID-19 pandemic is creating a growing shortage of PPE due to increased use for infection control.
This rapid learning provides strategies to help you conserve PPE so you can ensure it’s available whenever you need it.
We have created a specific page to link relevant COVID-19 resources for cancer health professionals and people with cancer and their carers.
**Reference Committee Update**
The production of L-asparaginase (also known as colaspase or brand name Leunase) has been discontinued by the manufacturer. This will impact a number of eviQ protocols.
Expressions of interest are invited for the position of eviQ BMT Reference Committee Co-Chair. Click the link to find out details. EOIs close by COB Sunday 14th June 2020.